Federal Register / Vol. 87, No. 87 / Thursday, May 5, 2022 / Notices 26769 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Ms. Mikia P. Currie, Chief, 

Project Clearance Branch (PCB), Office 

of Policy for Extramural Research 

Administration, 6705 Rockledge Drive, 

Suite 803–B, Bethesda, Maryland 20892, 

or call non-toll-free number (301) 435– 

0941 or Email your request, including 

your address to: curriem@mail.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Proposed Collection Title: Generic 

Clearance for Conferences, Meetings, 

Workshops, Poster Sessions and 

Registrations, exp., date 07/31/2022, 

Office of the Director (OD), National 

Institutes of Health (NIH). 

Need and Use of Information 

Collection: The information collection 

encompassed by this generic clearance 

continues to allow NIH to select the 

most appropriate participants for nongrantee activities sponsored, organized, 

and run by NIH staff, according to the 

type and purpose of the activity. For 

example, NIH may develop an 

application process or information 

collection to select a limited number of 

researchers to participate in a poster 

session, identify speakers and panelists 

with desired expertise on a specific 

topic to be covered at a meeting, or 

determine which researchers would 

mostly likely benefit from a training 

course or other opportunity. For NIH to 

plan and conduct activities that are 

timely for participants in their field of 

research, it is often necessary for such 

information to be collected within a 

relatively short turnaround time. In 

general, submitted abstracts or other 

application materials will be reviewed 

by an internal NIH committee 

responsible for planning the activities. 

This committee will be responsible for 

selecting and notifying participants. The 

information collected for these activities 

generally include title, author(s), and 

institution/organization, poster size and 

character limitations along with other 

requirements. This information is 

necessary to identify attendees eligible, 

present research, speak on panels, and 

discuss innovative approaches to 

science and technology for poster 

presentations among their peers. The 

registration form collects information 

from interested parties to register them 

and obtain the necessary qualifications 

for conferences, meetings, workshops, 

poster sessions, presentations and 

panels. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

8,875. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

(in hours) 

per response 

Total 

burden hours 

Conferences ..................................................................................................... 2,500 1 1 2,500

Meetings .......................................................................................................... 2,500 1 45/60 1,875 

Workshops ....................................................................................................... 2,500 1 30/60 1,250 

Poster Session ................................................................................................. 1,000 1 1 1,000 

Panels .............................................................................................................. 1,500 1 30/60 750 

Presentations ................................................................................................... 1,500 1 1 1,500

Total .......................................................................................................... ........................ 11,500 ........................ 8,875 

Date: April 27, 2022. 

Tara A. Schwetz, 

Acting Principal Deputy Director, National 

Institutes of Health. 

[FR Doc. 2022–09644 Filed 5–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Pathophysiological Basis of Mental 

Disorders and Addictions Study Section. 

Date: June 1–2, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Boris P. Sokolov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217A, 

MSC 7846, Bethesda, MD 20892, 301–408– 

9115, bsokolov@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Imaging 

Technology Development Study Section. 

Date: June 2–3, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


lotter on DSK11XQN23PROD with NOTICES1
26770 Federal Register / Vol. 87, No. 87 / Thursday, May 5, 2022 / Notices 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Guo Feng Xu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, 301–237– 

9870, xuguofen@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Neurotoxicology 

and Alcohol Study Section. 

Date: June 2–3, 2022. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sepandarmaz Aschrafi, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040D, 

Bethesda, MD 20892, (301) 451–4251, 

Armaz.aschrafi@nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Biobehavioral Medicine and Health 

Outcomes Study Section. 

Date: June 6–7, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mark A. Vosvick, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

Bethesda, MD 20892, (301) 402–4128, 

mark.vosvick@nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group; 

Bacterial Pathogenesis Study Section. 

Date: June 6–7, 2022. 

Time: 9:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Richard G. Kostriken, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 240–519– 

7808, kostrikr@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Community Influences on Health Behavior 

Study Section. 

Date: June 6–7, 2022. 

Time: 10:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pia Kristiina Peltola, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 594–9295, 

pia.peltola@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Radiation Therapeutics and Biology. 

Date: June 6, 2022. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Careen K. Tang-Toth, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

3504, tothct@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–20– 

131: Mammalian Models for Translational 

Research. 

Date: June 8, 2022. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jeffrey Smiley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6194, 

MSC 7804, Bethesda, MD 20892, 301–272– 

4596, smileyja@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Imaging Guided 

Interventions and Surgery Study Section. 

Date: June 9–10, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yuanna Cheng, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1195, Chengy5@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Motor Function, Speech and 

Rehabilitation Study Section. 

Date: June 9–10, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Biao Tian, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3166, MSC 7848, Bethesda, MD 

20892, (301) 402–4411, tianbi@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–OD– 

19–027: Resource-Related Research Projects 

for Development of Animal Models and 

Related Materials. 

Date: June 10, 2022. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jeffrey Smiley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6194, 

MSC 7804, Bethesda, MD 20892, 301–272– 

4596, smileyja@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group; Developmental Therapeutics Study 

Section. 

Date: June 13–14, 2022. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maureen Shuh, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 480–4097, 

maureen.shuh@nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Drug Discovery for the 

Nervous System Study Section. 

Date: June 16–17, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Aurea D. De Sousa, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

Bethesda, MD 20892, (301) 827–6829, 

aurea.desousa@nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neuronal Communications 

Study Section. 

Date: June 16–17, 2022. 

Time: 9:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Linda MacArthur, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4187, 

Bethesda, MD 20892, 301–537–9986, 

macarthurlh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–20– 

104: Biomedical Technology Development 

and Dissemination Center (RM1). 

Date: June 17, 2022. 

Time: 10:00 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Contact Person: Zarana Patel, Ph.D., 

Scientific Review Officer, The Center for 

Scientific Review, The National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–496–9295, zarana.shavers@

nih.gov. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 87 / Thursday, May 5, 2022 / Notices 26771 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Biomedical Research. 

Date: June 17, 2022. 

Time: 10:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joseph D. Mosca, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5158, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2344, moscajos@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 29, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–09593 Filed 5–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

ADVISORY COUNCIL ON HISTORIC 

PRESERVATION 

Notice of Intent To Request Public 

Comment on Draft Exemption From 

Historic Preservation Review for 

Electric Vehicle Supply Equipment 

AGENCY: Advisory Council on Historic 

Preservation. 

ACTION: Request for Public Comment on 

Draft Exemption from Historic 

Preservation Review for Electric Vehicle 

Supply Equipment. 

SUMMARY: The Advisory Council on 

Historic Preservation (ACHP) proposes 

an exemption that would relieve Federal 

agencies from the requirement of taking 

into account the effects of their 

undertakings on historic properties that 

involve the installation of certain 

electric vehicle supply equipment 

(EVSE). The proposed exemption would 

allow all Federal agencies to forego the 

historic preservation review process 

required for Federal undertakings and 

more quickly implement EVSE 

infrastructure for the Federal fleet. The 

public is invited to comment on the 

draft exemption before it is finalized 

and submitted for review and potential 

adoption by the ACHP. 

DATES: Submit comments on or before 

June 4, 2022. 

ADDRESSES: Address all comments 

concerning this exemption to Jaime 

Loichinger, Assistant Director, Advisory 

Council on Historic Preservation, at 

program_alternatives@achp.gov. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Loichinger, (202) 517–0219, 

jloichinger@achp.gov. 

SUPPLEMENTARY INFORMATION: Section 

106 of the National Historic 

Preservation Act, 54 U.S.C. 306108 

(Section 106 and NHPA), requires 

Federal agencies to consider the effects 

of their undertakings on historic 

properties, and provide the Advisory 

Council on Historic Preservation 

(ACHP) a reasonable opportunity to 

comment with regard to such 

undertakings. Historic properties are 

those properties that are listed in the 

National Register of Historic Places 

(National Register) or eligible for such 

listing. 

The NHPA authorizes the ACHP to 

promulgate regulations for exempting 

undertakings from any or all of the 

requirements of Section 106 (54 U.S.C. 

304108(c)). The Section 106 regulations, 

found at 36 CFR part 800, detail the 

process for the approval of such 

exemptions (36 CFR 800.14(c)). 

In accordance with section 800.14(c), 

the ACHP may approve an exemption 

for an undertaking if it finds that: (i) The 

actions within the program or category 

would otherwise qualify as 

‘‘undertakings’’ as defined in 36 CFR 

800.16; (ii) the potential effects of the 

undertakings within the program or 

category upon historic properties are 

foreseeable and likely to be minimal or 

not adverse; and (iii) exemption of the 

program or category is consistent with 

the purposes of the NHPA. 

I. Background 

In 2021, three Executive Orders were 

issued regarding Federal vehicle, or 

fleet, electrification: (1) E.O. 14005, 

Ensuring the Future is Made in All of 

America by All of America’s Workers, 

commits the Federal government to 

upgrade the entire Federal fleet to 

electric vehicles (EVs); (2) E.O. 14008, 

Tackling the Climate Crisis at Home and 

Abroad, prioritizes the development of 

a Federal Clean Electricity and Vehicle 

Procurement Strategy and directs 

Federal agencies to upgrade the entire 

Federal fleet to EVs; and (3) E.O. 14057, 

Catalyzing Clean Energy Industries and 

Jobs Through Federal Sustainability, 

sets a goal of 100 percent zero emission 

vehicle Federal acquisitions by 2035, 

including 100 percent light duty vehicle 

Federal acquisitions by 2027. 

Additionally, the Infrastructure 

Investment and Jobs Act (IIJA) of 2021 

(Pub. L. 117–58, 135 Stat. 429) 

appropriates $550 billion for new 

infrastructure investments. The IIJA 

includes provisions to increase 

investment in electric vehicle supply 

equipment (EVSE), alternative fuel 

infrastructure, EV batteries, electricity 

grid upgrades, and light-, medium-, and 

heavy-duty zero emission vehicles. 

Due to these requirements, Federal 

agencies are anticipated to propose 

activities to carry out, license, approve, 

or fund undertakings to electrify Federal 

vehicles and provide electric vehicle 

supply equipment (EVSE) that have the 

potential to affect historic properties 

and therefore, require Section 106 

review. 

An EV produces zero tailpipe 

emissions, dramatically lowering smog 

and greenhouse gas emissions even 

when considering electricity generation 

(EV refers to both Battery Electric 

Vehicles and Plug-in Hybrid Electric 

Vehicles). EVs have the potential to 

significantly improve Federal fleet 

efficiency and reduce vehicle operation 

and maintenance costs. EVs require 

EVSE. Commonly referred to as charging 

stations, EVSE is the hardware of the 

charging infrastructure that transfers 

energy to a vehicle. EVSE can be wallor pole-mounted, co-located or stand 

alone, and vary in design, size, charging 

speed and energy use. 

II. Exemption Concept and Criteria 

In considering how to address the 

anticipated increase in undertakings as 

a result of these requirements, the 

Department of Homeland Security 

(DHS) assembled an ad hoc working 

group of Federal Preservation Officers 

(FPOs) to discuss EV priorities and the 

potential effects of the EVSE program on 

historic properties. Through 

consultation with fleet technical 

experts, the working group defined the 

undertakings to be addressed by the 

proposed exemption as the installation, 

maintenance, repair, and expansion of 

Levels 1, 2, and 3 EVSE as defined by 

the General Services Administration. 

DHS approached the ACHP with the 

concept of the proposed exemption, at 

which time the ACHP determined it 

would avail itself of the regulatory 

process to propose the exempted 

category itself. The government-wide 

priority for fleet electrification and 

EVSE installation merited ACHP 

coordination of the proposal to ensure 

broad and appropriate consultation for 

an exemption likely to be applied across 

multiple Federal agency programs. 

The EVSE undertakings would require 

minimal changes to distinctive building 

materials, features, spaces, and spatial 

relationships, including landscapes and 

streetscapes. With few exceptions, these 

undertakings include co-location with 

existing electrical infrastructure; 

utilization of existing parking areas and 

structures; are incorporated within 

public transportation rights-of-way 


lotter on DSK11XQN23PROD with NOTICES1